Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 213


Identification of pancreatic cancer stem cells.

Li C, Heidt DG, Dalerba P, Burant CF, Zhang L, Adsay V, Wicha M, Clarke MF, Simeone DM.

Cancer Res. 2007 Feb 1;67(3):1030-7.


Identification of human pancreatic cancer stem cells.

Li C, Lee CJ, Simeone DM.

Methods Mol Biol. 2009;568:161-73. doi: 10.1007/978-1-59745-280-9_10.


Pancreatic cancer stem cells.

Lee CJ, Dosch J, Simeone DM.

J Clin Oncol. 2008 Jun 10;26(17):2806-12. doi: 10.1200/JCO.2008.16.6702. Review.


A novel mouse model of human breast cancer stem-like cells with high CD44+CD24-/lower phenotype metastasis to human bone.

Ling LJ, Wang S, Liu XA, Shen EC, Ding Q, Lu C, Xu J, Cao QH, Zhu HQ, Wang F.

Chin Med J (Engl). 2008 Oct 20;121(20):1980-6.


[Expression and significance of CD44(+)ESA(+)CD24(-/low), stem cell markers for breast cancer, in non-small-cell lung carcinoma].

Lu ZQ, Li HG, Zhang HZ, Fan MJ, Shen XM, He XX.

Ai Zheng. 2008 Jun;27(6):575-9. Chinese.


Semi-quantitative evaluation of CD44(+) /CD24(-) tumor cell distribution in breast cancer tissue using a newly developed fluorescence immunohistochemical staining method.

Kai M, Onishi H, Souzaki M, Tanaka H, Kubo M, Tanaka M, Katano M.

Cancer Sci. 2011 Dec;102(12):2132-8. doi: 10.1111/j.1349-7006.2011.02063.x. Epub 2011 Sep 14.


Expression of CD44, CD24 and ESA in pancreatic adenocarcinoma cell lines varies with local microenvironment.

Wei HJ, Yin T, Zhu Z, Shi PF, Tian Y, Wang CY.

Hepatobiliary Pancreat Dis Int. 2011 Aug;10(4):428-34.


Association of breast cancer stem cells identified by aldehyde dehydrogenase 1 expression with resistance to sequential Paclitaxel and epirubicin-based chemotherapy for breast cancers.

Tanei T, Morimoto K, Shimazu K, Kim SJ, Tanji Y, Taguchi T, Tamaki Y, Noguchi S.

Clin Cancer Res. 2009 Jun 15;15(12):4234-41. doi: 10.1158/1078-0432.CCR-08-1479. Epub 2009 Jun 9.


Isolation and biological analysis of tumor stem cells from pancreatic adenocarcinoma.

Huang P, Wang CY, Gou SM, Wu HS, Liu T, Xiong JX.

World J Gastroenterol. 2008 Jun 28;14(24):3903-7.


CD44(+)/CD24(-/low) cancer stem/progenitor cells are more abundant in triple-negative invasive breast carcinoma phenotype and are associated with poor outcome.

Idowu MO, Kmieciak M, Dumur C, Burton RS, Grimes MM, Powers CN, Manjili MH.

Hum Pathol. 2012 Mar;43(3):364-73. doi: 10.1016/j.humpath.2011.05.005. Epub 2011 Aug 10.


[Detection of breast cancer stem cells and the expression of key molecules in Hedgehog signaling pathway].

Lu ZH, Jia J, Ren J, Ma B, DI LJ, Song GH.

Beijing Da Xue Xue Bao. 2008 Oct 18;40(5):480-5. Chinese.


Pancreatic cancer stem cells: implications for the treatment of pancreatic cancer.

Simeone DM.

Clin Cancer Res. 2008 Sep 15;14(18):5646-8. doi: 10.1158/1078-0432.CCR-08-0584. Review.


The CD44+/CD24- phenotype is enriched in basal-like breast tumors.

Honeth G, Bendahl PO, Ringnér M, Saal LH, Gruvberger-Saal SK, Lövgren K, Grabau D, Fernö M, Borg A, Hegardt C.

Breast Cancer Res. 2008;10(3):R53. doi: 10.1186/bcr2108. Epub 2008 Jun 17.


[Analysis on clone in vitro and tumorigenic capacity in vivo of different subsets cells from the MCF-7 human breast cancer cell line].

Li Z, Liu CP, He YL, Tian Y, Huang T.

Sichuan Da Xue Xue Bao Yi Xue Ban. 2008 Jul;39(4):547-9. Chinese.


Tissue-specific promoters active in CD44+CD24-/low breast cancer cells.

Bauerschmitz GJ, Ranki T, Kangasniemi L, Ribacka C, Eriksson M, Porten M, Herrmann I, Ristimäki A, Virkkunen P, Tarkkanen M, Hakkarainen T, Kanerva A, Rein D, Pesonen S, Hemminki A.

Cancer Res. 2008 Jul 15;68(14):5533-9. doi: 10.1158/0008-5472.CAN-07-5288.


ALDH activity selectively defines an enhanced tumor-initiating cell population relative to CD133 expression in human pancreatic adenocarcinoma.

Kim MP, Fleming JB, Wang H, Abbruzzese JL, Choi W, Kopetz S, McConkey DJ, Evans DB, Gallick GE.

PLoS One. 2011;6(6):e20636. doi: 10.1371/journal.pone.0020636. Epub 2011 Jun 13.


Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties.

Ponti D, Costa A, Zaffaroni N, Pratesi G, Petrangolini G, Coradini D, Pilotti S, Pierotti MA, Daidone MG.

Cancer Res. 2005 Jul 1;65(13):5506-11.


Stem cells in mammary development and carcinogenesis: implications for prevention and treatment.

Dontu G, Liu S, Wicha MS.

Stem Cell Rev. 2005;1(3):207-13. Review.


CD44+/CD24- breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis.

Sheridan C, Kishimoto H, Fuchs RK, Mehrotra S, Bhat-Nakshatri P, Turner CH, Goulet R Jr, Badve S, Nakshatri H.

Breast Cancer Res. 2006;8(5):R59.

Supplemental Content

Support Center